We are live on ! Find out more
AG

Algert Global Portfolio holdings

AUM $8.43B
1-Year Est. Return 80.94%
This Fund
S&P 500
This Quarter Est. Return
+33.28%
1 Year Est. Return
+80.94%
3 Year Est. Return
+194.06%
5 Year Est. Return
+268.69%
10 Year Est. Return
+1,949.39%
AUM
$8.43B
AUM Growth
+$1.78B
Cap. Flow
+$499M
Cap. Flow %
5.91%
Top 10 Hldgs %
7.49%
Holding
1,437
New
303
Increased
525
Reduced
373
Closed
203

Sector Composition

Rank Sector Weight
1 Technology 19.85%
2 Industrials 16.3%
3 Financials 14.52%
4 Healthcare 14.02%
5 Consumer Discretionary 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTRN icon
276
Materion
MTRN
$5.09B
$9.86M 0.12%
33,140
+3,310
+11% +$693K
STX icon
277
Seagate
STX
$192B
$9.77M 0.12%
10,127
+6,993
+223% +$5.33M
EVLV icon
278
Evolv Technologies
EVLV
$906M
$9.68M 0.11%
1,669,103
+848,317
+103% +$5.31M
DDOG icon
279
Datadog
DDOG
$76.5B
$9.65M 0.11%
+37,045
New +$6.89M
TNET icon
280
TriNet
TNET
$3.17B
$9.62M 0.11%
194,450
+187,350
+2,639% +$8.03M
GH icon
281
Guardant Health
GH
$21.7B
$9.6M 0.11%
64,000
+6,570
+11% +$715K
FNF icon
282
Fidelity National Financial
FNF
$12.3B
$9.58M 0.11%
203,105
+43,175
+27% +$2.09M
SAFE
283
Safehold
SAFE
$1.07B
$9.55M 0.11%
608,243
-192,486
-24% -$2.92M
OMF icon
284
OneMain Financial
OMF
$7.44B
$9.51M 0.11%
155,915
+103,580
+198% +$5.83M
CARE icon
285
Carter Bankshares
CARE
$741M
$9.46M 0.11%
278,213
+121,433
+77% +$3.29M
TVTX icon
286
Travere Therapeutics
TVTX
$6.15B
$9.45M 0.11%
166,372
-10,536
-6% -$467K
ANF icon
287
Abercrombie & Fitch
ANF
$6.65B
$9.4M 0.11%
104,485
+9,928
+10% +$842K
M icon
288
Macy's
M
$6.06B
$9.4M 0.11%
399,090
-307,600
-44% -$6.44M
SGHC icon
289
SGHC Ltd
SGHC
$7.11B
$9.39M 0.11%
692,915
-439,787
-39% -$5.57M
BMY icon
290
Bristol-Myers Squibb
BMY
$136B
$9.33M 0.11%
161,894
+9,694
+6% +$557K
RAPP
291
Rapport Therapeutics
RAPP
$2.2B
$9.33M 0.11%
+223,822
New +$8.23M
CORZ icon
292
Core Scientific
CORZ
$5.75B
$9.32M 0.11%
364,340
+238,620
+190% +$5.62M
NXT icon
293
Nextpower Inc. Common Stock
NXT
$12.8B
$9.32M 0.11%
78,208
-265,634
-77% -$32.8M
EVR icon
294
Evercore
EVR
$11.5B
$9.3M 0.11%
27,229
+4,180
+18% +$1.43M
RAL
295
Ralliant Corp
RAL
$7.02B
$9.28M 0.11%
126,010
+102,670
+440% +$5.72M
RYTM icon
296
Rhythm Pharmaceuticals
RYTM
$7.07B
$9.26M 0.11%
83,431
+24,918
+43% +$2.25M
SNOW icon
297
Snowflake
SNOW
$117B
$9.26M 0.11%
+36,384
New +$6.7M
BAC icon
298
Bank of America
BAC
$438B
$9.24M 0.11%
162,088
+8,820
+6% +$469K
AGIO icon
299
Agios Pharmaceuticals
AGIO
$1.98B
$9.2M 0.11%
248,007
-20,428
-8% -$620K
DDS icon
300
Dillards
DDS
$10.3B
$9.19M 0.11%
+17,400
New +$10.1M

Similar funds

Algert Global's Q2 2026 Portfolio in Review

As of Q2 2026, Algert Global held 1,437 positions worth $8.43B, up 27% from $6.65B the previous quarter. Its ten largest holdings account for 7.5% of the portfolio.

Algert Global deployed $499M of net new capital in Q2 2026, opening 303 new positions and adding to 525 existing holdings. Its largest new stake was International Paper: 551,034 shares worth $21M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was MasTec, an estimated $36.8M trimmed.

  • Algert Global's largest Q2 2026 buy was International Paper: 551,034 shares worth $21M.
  • Algert Global added most to Toro Company in Q2 2026, an estimated $22M increase.
  • Algert Global's biggest Q2 2026 reduction was MasTec, cutting an estimated $36.8M.
  • Algert Global fully exited Taylor Morrison in Q2 2026, selling an estimated $33.3M.
  • Algert Global's ten largest holdings make up 7.5% of its $8.43B portfolio in Q2 2026.
  • Algert Global opened 303 new positions and closed 203 in Q2 2026.
  • Algert Global's portfolio value rose 27% quarter-over-quarter to $8.43B.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.